Table 1.
Study | Number of patients | Mean age (years) | Introcorporeal vs. Extracorporeal diversion | Mean operative time (minutes) | Postoperative complications (%) | Mean length of stay (days) | Mean follow-up (months) | Functional outcomes | Long-term complications |
---|---|---|---|---|---|---|---|---|---|
Augmentation cystoplasty | |||||||||
Gould and Stoffel[46] | 5 | 43.8 | Intracorporeal | 380 | 60% | 7 | 3 | 20% failure (persistent vesico-ureteral reflux) | NR |
Madec et al.[48] | 19 | 49 | Extracorporeal | 288.7 | 47.4% | 9.4 | 13.6 | Bladder pain syndrome (n=6): all improved Neurogenic bladder (n=13): 1 failure |
10.5% |
Flum et al.[49] | 21 | 30 | Intracorporeal | 365 | 38.9% | 6 | 38.9 | 47.9% decrease in bladder pressure | NR |
| |||||||||
Ileovesicostomy | |||||||||
Vanni and Stoffel[53] | 8 | 53 | Extracorporeal | 330 | 62.5% | 8 | 15 | 80% with resolved urinary incontinence 0% persistent hydronephrosis | One stomal complication One persistent |
Dolat et al.[54] | 4 | 45 | Intracorporeal | 289.5 | 12.5% | 7.5 | 25.8 | 75% with low stomal leak point pressure | One persistent high post-void residual |
| |||||||||
Cystectomy+ileal conduit | |||||||||
Deboudt et al.[43] | 40 | 58.6 | Extracorporeal | 299 | 35% | 10.9 | 21.9 | NR | 40% |
NR: Not reported; NA: Not applicable